Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,308 total articles
Lamar Advertising reported better-than-expected Q1 results with acquisition-adjusted revenue growth, robust national bookings and programmatic strength. The combination of high single-digit EBITDA growth, a 4.4% yield, remaining buyback authorization and an elevated short-interest backdrop creates a favorable risk-reward for a long trade over the n…
Paul Mueller Company just authorized a $440 tender offer for up to 35,000 shares and declared a $0.30 quarterly dividend. Those moves — a near-immediate cash takeout window and a recurring payout — create a clear asymmetric trade setup. Enter below $430, target $480, and use a $395 hard stop. Hold through the tender window and the dividend record d…
Micron’s business is benefiting from an accelerating, multi-year AI memory demand curve. Strong fundamentals, generous free cash flow, low leverage and clear end-market commitments from hyperscalers argue the market still underestimates how much DRAM and NAND need to scale. This trade idea lays out an actionable mid-term (45 trading days) long entr…
Johnson Controls (JCI) looks attractive on a tactical long. The shares trade at $139.29 with a $85.3B market cap, a mid-cycle P/E (~25) and solid ROE (26%). Growth drivers include commercial HVAC modernization, heat pumps, smart-home adoption and early wins in AI data-center cooling. Balance-sheet metrics and recurring revenue mix give the company …
AMD just pulled off a blowout quarter on AI accelerator demand. Valuation looks rich, but cash generation, low leverage and a broad product roadmap make AMD a more compelling long than Intel for capturing the agentic AI cycle. Trade plan included.
AstraZeneca delivered a strong Q1 with $15.29B revenue (up 13% YoY) and continued oncology-led growth, but stretched valuation metrics, near-term technical weakness and execution risk on late-stage assets make the stock a Hold. We lay out a neutral trade plan for mid-term traders: entry at $182.58, target $195.00, stop $172.00 (45 trading days).
UroGen is shifting from development to commercialization as ZUSDURI rollout accelerates. With market cap near $1.3B, negative EPS but improving commercial signals and elevated short interest, this is a directional long for investors who want exposure to a commercial-stage bladder cancer franchise heading toward profitability by 2027.
Sonos reported solid cash flow and improved operating cadence despite reported component cost pressure. With a market cap near $1.76B, positive free cash flow, and technical momentum, this is a tactical long setup for a mid-term swing (45 trading days) with a clearly defined stop and an upside target toward prior resistance.
CF Industries (CF) looks priced for a world with sustained fertilizer tightness. The recent ceasefire through the Strait of Hormuz — and the resulting collapse in oil — removes a near-term pricing tailwind. With a market cap around $18.3B, EPS of $9.47 and FCF of $1.8B, the business is healthy. Still, a sharper-than-expected drop in fertilizer real…
B2Gold reported results that came in firmer than the street feared, coupled with a $325m cash sale and a still-intact full-year guide. The stock is trading above key moving averages with improving technicals. Our tactical trade idea: go long at $5.075, target $6.20, stop $4.50, horizon mid term (45 trading days).
Ardmore (ASC) just doubled its dividend payout ratio to two-thirds of adjusted earnings, agreed to sell an older MR for $35.5m and contracted two new IMO2 mid-size tankers. With Q1 spot MR rates at $33,700/day and Q2 coverage improving toward $50,000/day, the set-up supports upgrading ASC to Buy for a mid-term trade. We provide an entry, stop and t…
Domino's Pizza (DPZ) has lost momentum after a weak Q1 and lowered guidance, but fundamentals and cash generation remain intact. The stock is trading near its 52-week low with oversold technicals and a manageable valuation. We outline a mid-term swing trade with a clear entry, stop and target, plus alternative longer-term scenarios for patient inve…
Uber enters earnings with strong free cash flow, a healthy balance sheet and a string of operational catalysts (robotaxi order, delivery scale). At ~$77, the stock offers an asymmetric setup: a near-term beat + raised guidance can re-rate the multiple toward growth peers and unlock 50% upside to ~$115.50 within ~180 trading days. Trade plan, risk c…
Samsara (IOT) is emerging from the 'SaaS apocalypse' narrative with accelerating enterprise traction, growing ARR and consecutive GAAP profitability. The market is pricing the stock like a cyclical growth story; we think it should be priced more like a data-first operational platform with durable gross margins and meaningful free cash flow. Trade i…
PayPal trades at roughly 9x earnings with free cash flow north of $5.5B and a market cap near $42.2B. The stock looks attractively priced for a turnaround trade, but recent margin pressure, competitive threats, and admitted tech underinvestment mean this is a tactical, conviction-thin long. Entry, stop and explicit time horizon included.
Meta trades at a reasonable multiple against robust revenue growth (33% YoY in Q1) and $48.3B in trailing free cash flow. The stock looks undervalued versus its growth profile, but the company needs a credible second growth engine beyond advertising to justify a higher valuation. This trade idea buys the dip with a clear stop and a 180-trading-day …
Celestica has become a direct beneficiary of the AI datacenter buildout. After a blowout quarter and a guidance raise, the stock pulled back sharply, creating a defined risk/reward for a long trade. This idea sizes the opportunity, lays out catalysts, and sets concrete entry, target and stop levels for a 180-trading-day horizon.
Microsoft's stock has ripped higher on renewed AI optimism. The fundamentals back the move: a $3.15 trillion market cap, strong cash flow, manageable leverage and an AI revenue run-rate narrative that can re-accelerate cloud monetization. This trade idea proposes a disciplined long entry at the current price with a $500 target over a 180-trading-da…
UBS ($UBS) is trading with bullish technical momentum, a reasonable valuation (P/E 15.5, P/B 1.52) and a shrinking short book after a recent analyst upgrade. This trade targets a move to the 52-week high at $49.36 over the next ~45 trading days, with a clear stop below the near-term moving averages to control downside.
Celldex’s barzolvolimab has shown durable, off-treatment responses in Phase 2 chronic spontaneous urticaria (CSU) data and the company has completed Phase 3 enrollment ahead of schedule. The balance sheet was bolstered by a public offering in April. This trade targets a mid-to-long term move on clinical and commercial optionality while keeping a de…
Tesla is trading at $405.60 after a sharp sentiment shift toward its autonomy and services story. With a market cap near $1.5 trillion, $7.0B in free cash flow, and improving technicals, the stock offers a tradeable mid-term long setup. The thesis leans on accelerating services/FSD monetization, robotaxi optionality, and better-margin geography mix…
Microsoft (MSFT) has pulled back from its 52-week highs but fundamentals remain intact: a $37B AI revenue run rate, Azure growth ~40% YoY per recent coverage, strong free cash flow of ~$72.9B and a fortress-like balance sheet. We recommend a tactical long entry on weakness with a mid-term and longer-term target, defined stop loss, and clear exit tr…
TRX Gold has pulled back sharply from its January highs while fundamentals and macro gold demand are improving. With fiscal 2025 revenue of $57.6M, EBITDA of $22M and a PEA forecasting 62,000 oz/year, the stock at a $404M market cap looks actionable as a swing trade. This idea lays out an entry, stop, targets and the key catalysts and risks to watc…
Taylor Devices (TAYD) is a small, profitable industrial with niche shock absorption and energy-management products, a healthy order backdrop in aerospace/defense and positive free cash flow. At a market cap near $175 million and a P/E in the mid-teens, the stock offers a reasonable risk-reward for a long-term trade if defense revenue and margin tra…
Palantir's Q1 results and commercial acceleration are showing the company is building an emergent AI control layer across government and enterprise. The market punished the stock on valuation concerns after an 85% revenue beat quarter; that selloff creates a tactical long opportunity. Entry $136.34, target $175.00, stop $115.00, mid-term horizon (4…
